However, any medication that is swallowed rather than absorbed sublingually will enter the digestive system, where peptides are typically broken down by enzymes before they can reach therapeutic targets
Psychopharmacology, 109 (4), 489-496
The combination of needle damage, pH mismatch, and the GLP-1 receptor agonist activity on local tissue receptors produces the characteristic burning or stinging sensation that usually subsides within 10-15 minutes
10.1186/s42494-023-00137-0 Acta Epileptol
What we know : BPC-157 shows remarkable effects in animal models Three small human studies report positive results and no adverse events Short-term tolerance appears acceptable based on limited data What we dont know : Long-term safety in humans Optimal dosing for various conditions Drug interactions Efficacy for most claimed uses in humans Whether animal benefits translate to people The regulatory reality : FDA has restricted compounding due to safety concerns WADA prohibits use by athletes No country has approved BPC-157 for therapeutic use If you choose to use BPC-157, do so with clear eyes about the evidence gaps
The point is that no two hair loss protocols look the same because no two patients lose their hair for the same reasons
